Eian Kantor

Jessica Thomas’ MS story

Jessica Thomas was driving one day when she realized she was having problems with her vision. Over the next couple of weeks, she began experiencing some unexplained numbness, tingling, and cognitive issues. “I had trouble coming up with words, which was super frustrating, as I was in graduate school at the time,” says Jessica. Within a couple of months from the onset of that very first symptom, ...

Continue reading

5 common clinical trial patient recruitment challenges and solutions

A lot can go wrong in clinical trial patient recruitment, leading to delays for up to 80% of all clinical trials. From underperforming sites to unresponsive patients, there are solutions to the most common patient recruitment challenges that can help accelerate your trial and ultimately beat your deadlines. Try these approaches if recruitment problems are putting the success of your trial at risk.

Continue reading

Discussing diversity in clinical trials with Clinical Ambassador’s Allison Kalloo

Many factors, such as age, biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background, can influence how individuals react to certain drugs, medical devices, and treatment plans.

Continue reading

Driving innovation in clinical trials and digital health: Impressions from SCOPE 2021

Celebrating its 12th successful conference, SCOPE Summit 2021 took place from March 2-4, 2021. Like most events during the COVID-19 pandemic, this year’s summit was fully virtual. During these unprecedented times, the work that the clinical research community does is more important than ever, and requires collaboration and innovation. Antidote’s Dave Mauro, Executive Vice President of Business ...

Continue reading

What is a COPD exacerbation?

When your COPD symptoms suddenly worsen, you may think you’re just having a really bad breathing day. This might, however, mean you’re having an exacerbation. A COPD exacerbation, also known as a COPD flare-up or episode, occurs when your COPD symptoms get worse than usual and may continue to get worse without extra treatment. The average annual rate of exacerbations in COPD patients is between ...

Continue reading

Five accounts to follow on social media if you're interested in inflammatory bowel disease

Inflammatory bowel disease, commonly referred to as IBD, is characterized by a group of intestinal disorders that cause inflammation of the digestive tract. Approximately 1.6 million Americans currently have IBD, and that number may be growing. The two most common kinds of IBD are ulcerative colitis (UC) and Crohn’s disease. Every person’s experience with IBD is different, but some of the more ...

Continue reading

What does patient centricity in research look like today?

Patient centricity is a phrase that generates a lot of buzz in the clinical research community — it typically refers to designing a treatment, clinical trial, or other health solution around patients’ needs and perspectives. Creating a patient-centric solution involves getting feedback from advocacy groups and patients themselves, and making decisions based on their voices. At the heart of it, ...

Continue reading

How to move respiratory research forward in the time of COVID

The COVID-19 pandemic has left everyone to adapt to a state of uncertainty. The medical community has been laser-focused on finding vaccines and treatments for COVID-19. Because of this, more than 1,000 clinical trials for other conditions have been delayed, paused, or deprioritized. Clinical trials for respiratory indications, in particular, have been impacted, especially because many lung ...

Continue reading

Is multiple sclerosis hereditary?

Multiple sclerosis (MS) is a disease of the central nervous system (brain and spinal cord). The cause of MS is not known, but scientists believe MS is triggered by some combination of these factors: immunologic, environmental, infectious, and genetic. If you live with MS and also have a family (or plan on starting one), you might be wondering if MS is passed down from generation to generation. We ...

Continue reading

Do you have a COPD action plan?

COPD, short for chronic obstructive pulmonary disease, is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. More than 16 million Americans are living with COPD, and millions more have it but don’t know it. Signs of COPD include ongoing cough, shortness of breath, lots of mucus, and chest tightness — but everyone will experience this disease differently.

Continue reading

Get our latest posts in your inbox